Investigation of the physicochemical properties and selective anti-cancer efficacy of in-plasma treated PBS using an exclusive liquid-submerged plasma jet
Abstract
Despite advances in current treatment options, cancer remains one of the leading causes of death, leading to nearly 10 million deaths in 2020. This highlights the urgent need for novel therapeutic alternatives. Plasma treated liquids (PTLs) have emerged as a promising alternative, primarily due to the generation of reactive oxygen and nitrogen species (RONS), such as H2O2, NO2-, and NO3-, during plasma treatment. In this study, a unique submerged plasma setup was used to produce high RONS concentrations in phosphate-buffered saline (PBS). The effects of plasma parameters, including gas flow rate, voltage, and treatment time, were systematically evaluated for their impact on H2O2 and NO2- concentration. Results showed that increasing treatment time and voltage significantly elevated both H2O2 and NO2- concentrations, whereas gas flow rate had minimal effect on both. Notably, the submerged setup generated exceptionally high H2O2 concentrations (>2000 µM), surpassing those typically reported in literature. Finally, the cytotoxic effects of the plasma treated PBS were assessed on human oral squamous cell carcinoma (OSCC) cells and healthy human keratinocytes (HaCaT) using cell proliferation and viability assays. The results demonstrated selective cytotoxicity, with a clear reduction in OSCC cell proliferation and viability, while sparing HaCaT cells. This selectivity underscores the strong potential of plasma treated PBS as a targeted cancer therapy that minimizes damage to healthy tissue.